Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeHealth

      Health

      BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
      Health

      BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance

      July 31, 2026
      Cytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales
      Health

      Cytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales

      July 30, 2026
      Regeneron Reports Second Quarter 2026 Financial and Operating Results
      Health

      Regeneron Reports Second Quarter 2026 Financial and Operating Results

      July 30, 2026
      K-BRO APPOINTS JOHN LYNCH TO ITS BOARD OF DIRECTORS
      Health

      K-BRO APPOINTS JOHN LYNCH TO ITS BOARD OF DIRECTORS

      July 30, 2026
      Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas
      Health

      Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas

      July 30, 2026
      INOVIO Announces Pricing of $20.0 Million Public Offering
      Health

      INOVIO Announces Pricing of $20.0 Million Public Offering

      July 30, 2026
      MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF
      Health

      MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF

      July 29, 2026
      Integra LifeSciences Reports Second Quarter 2026 Financial Results
      Health

      Integra LifeSciences Reports Second Quarter 2026 Financial Results

      July 29, 2026
      CVS Pharmacy® celebrates opening of first pharmacy-focused location in Houston
      Health

      CVS Pharmacy® celebrates opening of first pharmacy-focused location in Houston

      July 17, 2026
      Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026
      Health

      Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026

      July 17, 2026
      1 2 3 … 212 »

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026